TLDR NYT adds 1.29M digital subs, pushing digital base near 12M strong. Digital revenue up 14%, offsetting print decline for solid gains. Profit jumps 36.6% with margin at 18.7% amid tight cost control. Free cash flow surges 65% as NYT boosts digital efficiency. NYT repurchases shares, tackles AI legal costs, stays growth-focused. The New York [...] The post The New York Times Company (NYT) stock: rises on 1.29M new digital subs and 14% digital revenue boost appeared first on CoinCentral.TLDR NYT adds 1.29M digital subs, pushing digital base near 12M strong. Digital revenue up 14%, offsetting print decline for solid gains. Profit jumps 36.6% with margin at 18.7% amid tight cost control. Free cash flow surges 65% as NYT boosts digital efficiency. NYT repurchases shares, tackles AI legal costs, stays growth-focused. The New York [...] The post The New York Times Company (NYT) stock: rises on 1.29M new digital subs and 14% digital revenue boost appeared first on CoinCentral.

The New York Times Company (NYT) stock: rises on 1.29M new digital subs and 14% digital revenue boost

TLDR

  • NYT adds 1.29M digital subs, pushing digital base near 12M strong.
  • Digital revenue up 14%, offsetting print decline for solid gains.
  • Profit jumps 36.6% with margin at 18.7% amid tight cost control.
  • Free cash flow surges 65% as NYT boosts digital efficiency.
  • NYT repurchases shares, tackles AI legal costs, stays growth-focused.

The New York Times Company (NYT) reported strong third-quarter 2025 results, prompting a 1.56% rise in its stock price.

The New York Times Company (NYT)

The company closed early afternoon trading on November 5, 2025, at $58.65, showing renewed momentum. The rise followed a sharp increase in digital subscribers and revenue.

NYT added 1.29 million digital-only subscribers year-over-year, pushing its total digital base to 11.76 million. From the previous quarter, it gained 460,000 digital-only subscribers, highlighting consistent demand. Of the total, 6.27 million users subscribed to bundled or multiproduct offerings.

This digital expansion lifted revenue, as average revenue per user (ARPU) rose 3.6% year-over-year to $9.79. The growth came as many subscribers moved from discounted rates to standard pricing tiers. This pricing shift contributed significantly to NYT’s financial performance.

Digital Subscription and Advertising Drive Revenue Gains

Total subscription revenue increased 9.1% year-over-year to $494.6 million in the third quarter of 2025. Digital-only subscription revenue surged 14.0% to $367.4 million, offsetting a 3.0% drop in print subscription revenue. Print revenues declined due to weaker domestic delivery and lower single-copy sales.

Advertising revenue also strengthened, growing 11.8% year-over-year to $132.3 million in the third quarter. Digital advertising led this growth, increasing 20.3% to $98.1 million due to higher demand and expanded ad inventory. In contrast, print advertising declined 7.1% to $34.2 million.

Other revenue streams added to the performance, with affiliate, licensing, and other revenues rising 7.9% to $73.9 million. Licensing activity remained strong and contributed notably to this segment. Overall, NYT posted total revenue of $700.8 million, up 9.5% from a year ago.

Profitability and Operational Metrics Reflect Strong Execution

Operating profit jumped 36.6% year-over-year to $104.8 million, with an adjusted operating profit of $131.4 million. The operating margin reached 15.0%, while the adjusted margin stood at 18.7%, both reflecting solid gains. Diluted earnings per share rose by $0.11 to $0.50, with adjusted EPS increasing by $0.14 to $0.59.

Operating costs increased 5.8% to $596.0 million, driven by higher journalism, marketing and product development costs. Adjusted operating costs rose 6.2% to $569.4 million, indicating tight cost management. Sales and marketing expenses rose 15.1% as media costs climbed 18.0%.

Free cash flow reached $392.9 million for the first nine months of 2025, up from $237.7 million a year earlier. The company attributed part of this increase to tax benefits under the One Big Beautiful Bill Act. NYT also finalized a land sale in College Point, N.Y., contributing $33 million in net proceeds.

During the quarter, NYT repurchased 482,833 Class A shares, spending approximately $27.3 million. As of October 31, 2025, $393 million remains authorized for future share repurchases. This repurchase activity supports shareholder returns amid improved financial health.

The company incurred a $3.5 million impairment charge related to a nonmarketable equity investment, affecting net income slightly. NYT recorded $2.4 million in legal expenses tied to its ongoing AI litigation against Microsoft and OpenAI. These costs, treated as special items, reflect management’s stance on one-time legal matters.

Capital expenditures totaled $8 million during the quarter, rising modestly from $6 million a year earlier. The company maintained disciplined investment in infrastructure and technology. These efforts align with NYT’s digital-first strategy and operational efficiency.

The post The New York Times Company (NYT) stock: rises on 1.29M new digital subs and 14% digital revenue boost appeared first on CoinCentral.

Market Opportunity
Boost Logo
Boost Price(BOOST)
$0.001432
$0.001432$0.001432
+0.42%
USD
Boost (BOOST) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23